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␤-adrenergic receptors; protein phosphatases; protein kinase A; calmodulin-dependent protein kinase II; ryanodine receptors HEART FAILURE is a progressive disorder that is initiated after cardiovascular events damage the heart muscle or disrupt the ability of the myocardium to generate force (21) . Altered Ca 2ϩ cycling plays a predominant role in disturbed myocardial function in heart failure (2) . In cardiac myocytes, rapid Ca 2ϩ influx through L-type Ca 2ϩ channels (LTCCs) during an action potential (AP) opens ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR) to release Ca 2ϩ from SR [Ca 2ϩ -induced Ca 2ϩ release (CICR)] (7, 8, 24, 36, 37) . CICR in ventricular myocytes takes place mainly at dyads or peripheral junctions where RyRs on the SR are closely apposed to LTCCs in t-tubular (TT) or surface sarcolemmal (SS) membranes, respectively (9, 36) . In mammalian ventricular myocytes, TT membranes contain substantially higher LTCC current density than SS membranes (17) and play an essential role in excitation-contraction coupling (32) . When the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) increases, Ca 2ϩ binds to troponin C and removes the inhibitory effect of a troponin-tropomyosin complex on the actin-myosin interaction, consequently allowing force generation and shortening of myocytes (33) . Sarco-(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2 then cycles ϳ70% of the released Ca 2ϩ back into the SR, whereas sarcolemmal Na ϩ /Ca 2ϩ exchangers (NCXs) convey most of the remaining Ca 2ϩ into the extracellular space (2, 8) . SERCA2 activity is regulated by a phosphoprotein in the SR, phospholamban (PLB) (20) . Dephosphorylated PLB decreases the affinity of SERCA2 for Ca 2ϩ , and the phosphorylation of PLB by PKA or Ca 2ϩ /calmodulin-dependent kinase II (CaMKII) relieves its inhibitory effect on SERCA2. When [Ca 2ϩ ] i decreases to the resting level, Ca 2ϩ is dissociated from troponin C, and the contraction ceases.
In heart failure, peak systolic [Ca 2ϩ ] i is decreased at a physiological heart rate (2) . In most heart failure, SR Ca 2ϩ content decreases due to the suppression of SERCA2, enhancement of sarcolemmal NCXs, and leaky RyRs (2). These alterations usually result from a decrease or an increase in the expression level of SERCA2 and NCXs, respectively (18) , and a change in the phosphorylation level of PLB and RyRs. In heart failure, phosphorylation of PLB by PKA and CaMKII is decreased (20) . On the other hand, RyRs are hyperphosphorylated by PKA and CaMKII in heart failure (1, 22) . This renders RyRs hypersensitive to Ca 2ϩ and causes a diastolic Ca 2ϩ leak through RyRs, a decrease in SR Ca 2ϩ content, and fatal ventricular arrhythmias based on delayed afterdepolarizations.
In some forms of cardiac hypertrophy and failure, the CICR gain (i.e., the amount of Ca 2ϩ released from the SR normalized to Ca 2ϩ influx through LTCCs) decreases despite the normal whole cell LTCC current density, RyR number, and SR Ca 2ϩ content (10, 11, 23) . This decrease in CICR gain has been proposed to arise from a change in dyad architecture (10, 11) or derangement of the TT structure (14) . In these studies, however, CICR gain was defined in relation to whole cell but not TT Ca 2ϩ influx, although ventricular excitation-contraction coupling is mainly mediated by TT LTCCs (32) . It is also noteworthy that in human failing ventricular myocytes, SS LTCC activity was increased by ϳ200%, whereas the whole cell LTCC current density was not altered, indicating that the TT LTCC current density might have decreased (31) . Thus, the "decreased CICR gain" might reflect a decrease in TT Ca   2ϩ influx. Therefore, we assessed the LTCC current density in SS and TT membranes of failing ventricular myocytes of mice chronically treated by a ␤-adrenergic agonist, isoproterenol (Iso). We found, for the first time, that the TT LTCC current density was halved, whereas the SS LTCC current density was significantly increased, in Iso-treated versus control myocytes. The decreased TT LTCC current density resulted from insufficient activation by kinases other than PKA or CaMKII and excessive suppression by protein phosphatase 1/2A (PP1/2A) of TT LTCCs in Iso-treated versus control myocytes. SS LTCCs were activated by kinases other than PKA and CaMKII in both control and Iso-treated myocytes, whereas they were less strongly suppressed by PP1/2A in Iso-treated versus control myocytes. These results indicate that excessive ␤-adrenergic stimulation causes the decrease in TT LTCC current density by altering the regulation of LTCCs by protein kinases and PPs in heart failure. This phenomenon might underlie the decreased CICR gain in heart failure.
MATERIALS AND METHODS
Solutions and chemicals. The composition of modified Tyrode solution and external solution 1 is shown in Table 1 . The composition of pipette solutions is shown in Table 2 . In some experiments, EGTA in pipette solution 2 was replaced with 10 mM BAPTA. Chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan) unless otherwise indicated. Staurosporine (SP) was prepared as 100 mol/l stock solutions in 100% DMSO; H-89 (Enzo Life Science, Plymouth Meeting, PA) and KN-93 (Sigma-Aldrich, St. Louis, MO) were prepared as 1 mmol/l stock solutions in 100% DMSO; and okadaic acid (OA) and cyclosporin A (CsA) (Calbiochem, La Jolla, CA) were prepared 10 mmol/l stock solutions in 100% DMSO. These stock solutions were kept at Ϫ20°C until use. When used in experiments, final concentrations of these drugs were applied to myocytes at least 30 min before LTCC currents were measured. Finally, 0.1% DMSO did not significantly affect LTCC currents.
Animal model. This investigation conformed with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) . All experiments were carried out in accordance with the "Guidelines for Animal Experimentation" of Shinshu University and Juntendo University and were approved by the Committee for Animal Experimentation of both universities. Male C57BL/6 adult mice (8 -10 wk old) were purchased from Japan SLC (Hamamatsu, Shizuoka, Japan). Cardiac hypertrophy and failure were induced in the mice by the subcutaneous injection of 6 mg/kg Iso once daily for 21 days (Iso-treated mice). Age-matched normal control mice received the same volume of saline only. Animals were used for experiments at least 24 h after the last injection. Animals were euthanized with pentobarbital sodium (30 mg/kg) applied intraperitoneally. The heart and lungs were excised from the animals, rinsed in ice-cold modified Tyrode solution, and weighed. Heart weight (HW; in mg) and lung weight (LW; in mg) were normalized to body weight (BW; in g) (i.e., HW/BW and LW/BW). However, the BW of Iso-treated mice (28.6 Ϯ 0.4 g) was significantly higher than that of control mice (26.0 Ϯ 0.8 g; see Supplemental Material, Supplemental Table 1) . 1 Thus, HW and LW were also normalized to tibial length (TL; in mm) (i.e., HW/TL and HW/TL), which was not significantly altered in Iso-treated versus control mice (19.13 Ϯ 0.23 vs. 19.25 Ϯ 0.16 mm, respectively).
Ultrasound cardiography. Cardiac function was assessed with ultrasound cardiography (GE Yokogawa Medical System, Tokyo, Japan) in anesthetized mice, as previously described (16) . Hearts were viewed at the level of the papillary muscles in the short axis. In M-mode tracings, the average of three consecutive beats was used to measure the following parameters: interventricular septum thickness, left ventricular (LV) end-diastolic dimension (EDD) and end-systolic dimension (ESD), and fractional shortening (FS), which was calculated as follows: (EDD Ϫ ESD)/EDD ϫ 100%.
Assessment of hemodynamics. Cardiac catheter examination by a closed-chest approach was performed in control and Iso-treated mice. Under anesthesia with pentobarbital sodium (30 mg/kg), a micropressure transducer with an outer diameter of 0.42 mm (Samba 201, Samba Sensors, Stockholm, Sweden) was inserted through the right carotid artery into the aorta and then into the LV. LV end-diastolic pressure, LV end-systolic pressure, and the maximal and minimum rates of LV pressure development (dP/dtmax and dP/dtmin, respectively) were measured using a PowerLab system (version 6.1.1, AD Instruments Japan, Nagoya, Japan) with a sampling rate of 2 kHz before and after the subcutaneous application of 6 mg/kg Iso. LV end-systolic pressure, dP/dtmax, and dP/dtmin reached their peak within 3 min after Iso application. Figure 1E and Supplemental Table  3 show the values of these parameters before Iso application and at the peak after Iso application.
Gross and histological evaluation of hearts. Hearts were fixed in 20% phosphate-buffered formalin at room temperature for 24 h and 1 Supplemental Material for this article is available at the American Journal of Physiology-Heart and Circulatory Physiology website. cut longitudinally or transversely to obtain four-chamber sections or ventricular cross-sections, respectively. Tissues were then embedded in paraffin and cut into 4-m-thick slices. Histological sections were stained with hematoxylin-eosin or Masson trichrome and examined with a light microscope (BX-51, Olympus, Tokyo, Japan). Measurements of the wall thickness (i.e., the mean thickness of the anterior, lateral, posterior, and septal walls) and chamber diameter (i.e., the mean of the shortest and longest distances between the endocardial surfaces) of the LV were carried out with an objective micrometer as the scale on digital microscopic images taken from histological sections. The degree of interstitial fibrosis and myocyte hypertrophy were examined in each animal.
Assessment of expression of proteins involved in excitation-contraction coupling.
Hearts isolated from anesthetized mice were homogenized in 5 volumes of buffer containing 20 mM HEPES (pH 7.5) and protease inhibitor cocktail (Roche) by a polytron-type homogenizer. The homogenate was centrifuged at 8,900 g at 4°C for 10 min to remove debris, and the membrane fraction was collected by ultracentrifugation at 100,000 g at 4°C for 45 min. The resultant pellets were homogenized in a T-PER Tissue Protein Extraction reagent (Thermo Fisher Scientific, Waltham, MA) and rotated for 30 min at 4°C to solubilize proteins. Insoluble materials were removed by centrifugation at 10,000 g at 4°C for 10 min, and supernatants were used for subsequent analysis. The protein concentration of the samples was determined by a BCA protein assay kit (Thermo Fisher Scientific).
The yielded membrane fractions were separated on SDS-PAGE and electroblotted onto polyvinylidene difluoride membranes. Nonspecific binding was blocked with 5% nonfat skim milk in Trisbuffered saline with Tween 20 (TBST) for 1 h at room temperature. TBST contained 150 mM NaCl, 100 mM Tris, and 0.1% Tween 20 (pH adjusted to 7.4 with HCl). Membranes were incubated with rabbit polyclonal anti-Ca v1.2 antibody (Ab; 1:1,000, Alomone Labs, Jerusalem, Israel), mouse monoclonal anti-␤ 2 subunit Ab (1:1,000, clone 6C4, Abnova, Taipei, Taiwan), mouse monoclonal anti-dihydropyridine receptor ␣ 2-subunit Ab (1:500, clone 20A, Novus Biologicals, Littleton, CO), mouse monoclonal anti-PLB Ab (1:500, clone 2D12, Thermo Fisher Scientific), mouse monoclonal anti-SERCA2 Ab (1: 1,000, clone 2A7-A1, Thermo Fisher Scientific), mouse monoclonal anti-RyR Ab (1:500, clone 34C, Affinity Bioreagent, Golden, CO), or mouse monoclonal anti-NCX Ab (1:1,000, clone C2C12, Thermo Fisher Scientific) overnight at 4°C. After being washed with TBST, membranes were reacted with horseradish peroxidase-conjugated donkey anti-rabbit or anti-mouse IgG (1:10,000, Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room temperature. The bound secondary Abs were visualized with ECL-Plus reagent (BD Biosciences, San Jose, CA) according to the manufacturer's instructions. Signal intensities of the bands were quantified with the Gel analysis program of ImageJ software (NIH, Bethesda, MD).
Isolation of cardiac myocytes. Ventricular myocytes were enzymatically isolated as previously described (37) . Briefly, the heart was quickly removed, mounted on a Langendorff apparatus, and immediately reperfused with modified Tyrode solution at 37°C for 5 min. The heart was subsequently perfused with nominally Ca 2ϩ -free Tyrode solution at 37°C for 3 min and then with Ca 2ϩ -free Tyrode solution containing 0.80 mg/ml collagenase, 0.06 mg/ml protease (SigmaAldrich), 1.20 mg/ml hyaluronidase (Sigma-Aldrich), 0.03 mg/ml DNase I (Roche), and 0.50 mg/ml BSA at 37°C for a further 2 min. The digested heart was detached from the Langendorff apparatus, and the ventricles were cut into small pieces with fine scissors and vigorously shaken in the same solution containing the enzymes. After ventricular myocytes were isolated and sedimented, the supernatant was discarded. Ventricular myocytes were resuspended in Ca 2ϩ -free Tyrode solution containing 1 mg/ml BSA at room temperature. This procedure was repeated several times to dilute enzymes and terminate digestion. Thereafter, the Ca 2ϩ concentration was gradually increased to 1.8 mmol/l to obtain quiescent ventricular myocytes.
Morphological analysis of t-tubules. Isolated ventricular myocytes were incubated with a membrane-staining dye, di-8-aminoaphthylethenylpyridinium (di-8-ANEPPS; 10 mol/l, Molecular Probes, Eugene, OR) for 15 min and washed for 10 min at room temperature. An x-y image was recorded at the center of the myocyte with a confocal microscope (TCS SP2 AOB, Leica Microsystems, Wetzlar, Germany) with excitation at 488 nm and emission at 526 -673 nm. Image processing was carried out principally according to Heinzel et al. (14) . Briefly, x-y images were deconvolved based on the measured point spread function using ImageJ software. The point spread function was quantified by measuring the full-width half-maximum (FWHM) of subresolution fluorescent beads (⌽ ϭ 0.1 m) in crystalline solution (TetraSpeck Fluorescent Microspheres Size kit, Invitrogen, Carlsbad, CA). The FWHM was 0.384 m in the x-and y-directions and 0.701 m in the z-direction. SS and TT signals were identified against the background by the Otsu thresholding algorithm, resulting in a binary image. Signal-positive pixels in SS and TT areas were manually separated and counted. The normalized TT area was quantified as the ratio of the number of signal-positive pixels in the TT area to that in the SS area (i.e., TT/SS) (19) .
Detubulation. Detubulation of isolated ventricular myocytes was carried out with an osmotic shock as previously described (17) . Myocytes were treated with modified Tyrode solution containing formamide (1.5 mol/l) for 15 min and returned to modified Tyrode solution. To quantify the effectiveness of detubulation (␣), the above image processing was carried out for detubulated myocytes, and the TT area of detubulated myocytes was normalized to that of nondetubulated myocytes.
Electrophysiology. The liquid junction potential of both pipette solutions 1 and 2 in relation to modified Tyrode solution was Ϫ11 mV. This value was taken into consideration throughout this study.
APs and membrane currents of isolated ventricular myocytes were studied in the whole cell configuration of the patch-clamp technique at 35-37°C with a patch-clamp amplifier (Axopatch 200B, Molecular Devices, Sunnyvale, CA). Patch pipettes were fabricated from borosilicate glass capillaries (Kimax-51, Kimble Glass, Vineland, NJ).
APs were measured with pipette solution 1. The external solution was modified Tyrode solution. APs were elicited under a current clamp by injecting a rectangular current pulse of 2-to 5-nA amplitude and 2-ms duration every 0.25 s.
To measure LTCC currents, the whole cell configuration was formed with pipette solution 2 and modified Tyrode solution. After the whole cell configuration was established, triple pulses to Ϫ111, Ϫ51, and Ϫ1 mV (300-ms duration for each pulse) were continuously applied to myocytes from a holding potential of Ϫ91 mV every 3 s. These triple pulses activated mainly inward rectifier K ϩ , voltagedependent Na ϩ , and LTCC currents, respectively. The bathing solution was switched to external solution 1. About 1 min after these channel currents except for LTCC currents were completely suppressed, the membrane potential was stepped from Ϫ91 to Ϫ61 mV for 1 s and then for 500 ms to potentials between Ϫ111 and ϩ69 mV with a 10-mV increment every 3 s. LTCC currents were isolated as the current inhibited by Cd 2ϩ (100 mol/l) plus nifedipine (10 mol/l) in external solution 1 (37) . The peak amplitude of LTCC currents evoked by the 500-ms test pulse was plotted against the membrane voltage.
To assess SS and TT LTCC current densities, the peak LTCC current amplitude at Ϫ1 mV and the membrane capacitance were measured in nondetubulated and detubulated myocytes. The following equations describe the relationship between current density, current amplitude, and membrane capacitance:
where CN, CD, CSS, and CTT are the membrane capacitance of nondetubulated myocytes, detubulated myocytes, SS, and TT membranes, respectively; I N and ID is the peak LCC current amplitude at Ϫ1 mV of nondetubulated and detubulated myocytes, respectively; D SS and DTT are the LTCC current densities of SS and TT membranes, respectively; and ␣ is the fraction of TT membranes remaining in detubulated myocytes. Thus, CSS, CTT, DSS, and DTT were calculated from the following equations:
From the binary image analysis of nondetubulated and detubulated myocytes (see Fig. 3D ), ␣ was estimated as 0.18 Ϯ 0.03 and 0.16 Ϯ 0.02 in control and Iso-treated myocytes, respectively (P ϭ 0.675) and set at 0.17 in these calculations. These calculations are based on the assumption that the density of TT membranes is homogeneous in the z-direction in nondetubulated and detubulated myocytes and, thus, that the ␣-value reflects the efficiency of detubulation in whole myocytes. Because nondetubulated and detubulated myocytes were different groups of myocytes, the above calculation was carried out with the mean membrance capacitance and current amplitude of each group. We assumed that LTCCs did not move between SS and TT membranes during detubulation.
Analysis of electrophysiological data. The recorded membrane currents and voltage were lowpass filtered at 10 kHz (Ϫ3 dB), digitized at 47.2 kHz with a PCM converter system (VR-10B, Instrutech, New York, NY), and recorded on videocassette tapes. For offline analysis, data were reproduced, lowpass filtered at 2 kHz (Ϫ3 dB), digitized at 5 kHz with an analog-to-digital converter (ITC16I, Instrutech), and analyzed with Patch Analyst Pro (MT, Hyogo, Japan).
Statistical analysis. Data are expressed as means Ϯ SE. Statistical significance was evaluated with Student's paired or unpaired t-test. For the multiple comparison of data, ANOVA with Bonferroni's test was used. P Ͻ 0.05 was considered significant.
RESULTS

Chronic treatment of mice with Iso induces cardiac hypertrophy and failure.
Mice were chronically treated with saline (control) or Iso for 21 days. Iso-treated mice showed cardiac hypertrophy and dilation of chambers compared with control mice (Fig. 1, A and B, and Supplemental Table 1 ). LV wall thickness and chamber diameter were significantly greater in Iso-treated than in control mice (Fig. 1B) . HW or LW normalized to BW or TL was also significantly greater in Iso-treated versus control mice, indicating that Iso-treated mice suffered from cardiac hypertrophy and failure. Masson trichrome staining of the myocardium (LV) showed that the diameter of each myocyte was larger but that the extent of fibrosis was comparable in control versus Iso-treated mice (Fig. 1C) . Ultrasound cardiograms showed that EDD and ESD of the LV were significantly increased and that FS of the LV was significantly decreased in Iso-treated versus control mice (Fig. 1D and Supplemental Table 2 ). Hemodynamic assessment before and after the subcutaneous injection of 6 mg/kg Iso indicated that LV end-diastolic pressure was significantly higher, whereas dP/dt max was significantly smaller, in Iso-treated mice than in control mice (Fig. 1E and Supplemental Table 3 ). APs of LV myocytes obtained from Iso-treated mice were significantly longer than those of control mice due to the suppression of transient outward K ϩ currents in Iso-treated versus control myocytes ( Fig. 1F and Supplemental Fig. 1 ). These results indicate that Iso-treated mice suffered from cardiac hypertrophy and failure (28) .
Expression of Ca 2ϩ -handling proteins. Figure 2A shows the Western blot analysis of ␣ 1C -, ␤ 2 -, and ␣ 2 ␦-subunits of LTCCs. Expression of these proteins was not significantly altered in Iso-treated versus control mice. The expression of Ca 2ϩ -handling proteins such as PLB, SERCA2, and NCX1 can be altered in heart failure (2, 18, 29) . However, the expression of these proteins was also not significantly changed in Iso-treated versus control mice (Fig. 2B) .
TT structures and the efficiency of detubulation. TT structures are distorted in some forms of heart failure (13, 14, 34) . Figure 3A shows binary images of control and Iso-treated Crude membrane fractions of the heart were subjected to SDS-PAGE and immunoblot analysis. Right: expression levels of each protein. Band intensities in Western blots were quantified and normalized to those of control hearts. PLB, phospholamban; SERCA2, sarco(endo)-plasmic reticulum Ca 2ϩ -ATPase 2; RyR, ryanodine receptor; NCX1, Na ϩ /Ca 2ϩ exchanger isoform 1. Graphs show means Ϯ SE; n ϭ 4 for each group. ventricular myocytes stained with the membrane-staining dye di-8-ANEPPS. The gross appearance of t-tubules was similar between the two groups of myocytes (Fig. 3, left) . The areas of whole cell, SS, and TT membranes were significantly larger in Iso-treated myocytes than in control myocytes ( Fig. 3B and Supplemental Table 4 ), consistent with the cardiac hypertrophy of Iso-treated mice. However, TT/SS was not significantly different between the two groups of myocytes (Fig. 3C) , indicating that TT structures were not significantly distorted in Iso-treated myocytes.
In the following experiments, we acutely occluded t-tubules (i.e., detubulation) to assess SS and TT LTCC current densities. Figure 3A , right, shows images of detubulated myocytes, where only a few TT signals were detected. Figure 3B shows that detubulation significantly reduced the area of whole cell and TT membranes but not SS membranes in both control and Iso-treated myocytes. Accordingly, detubulation significantly reduced TT/SS (Fig. 3C) . Figure 3D shows that the TT area of detubulated myocytes normalized to that of nondetubulated myocytes (␣ was 0.18 Ϯ 0.03 and 0.16 Ϯ 0.02 in control and Iso-treated myocytes, respectively, P ϭ 0.675).
LTCC currents in SS and TT membranes. LTCC currents play a pivotal role in cardiac excitation-contraction coupling (24) . As shown in Fig. 4A , whole cell LTCC current amplitude and kinetics were similar in control and Iso-treated myocytes. Table 3 shows that there were no significant difference in the biophysical properties of whole cell LTCCs between control and Iso-treated mice (see also Supplemental Fig. 2) (25) .
In rat ventricular myocytes, LTCC current density has been reported to be approximately nine times higher in TT and SS membranes (17) . We measured LTCC currents in mouse myocytes with or without detubulation. Significantly, detubulation more greatly reduced LTCC currents in control myocytes than in Iso-treated myocytes (Fig. 4A and Supplemental Table 5 ), indicating that TT LTCC currents were decreased in Iso-treated versus control myocytes. The peak current-voltage relationships shown in Fig. 4B demonstrate that detubulation decreased LTCC currents by ϳ62% in control myocytes but only by ϳ37% in Iso-treated myocytes. Figure 4C shows that detubulation significantly reduced the membrane capacitance in both control and Iso-treated myocytes. Membrane capacitance was significantly higher in Iso-treated myocytes than in control myocytes with or without detubulation. From these data and the ␣-value shown in Fig. 3D (set at 0.17) , we assessed the membrane capacitance of whole cell, SS, and TT membranes using Eqs. 5 and 6 (Fig. 4D) . These calculations are based on the assumption that the density of TT membranes is homogeneous in the z-direction in nondetubulated and detubulated myocytes and, thus, that the ␣-value reflects the efficiency of detubulation in whole myocytes. The whole cell, SS, and TT membrane capacitance was higher in Iso-treated myocytes than in control myocytes, again consistent with the cardiac hypertrophy of Iso-treated mice. From the membrane capacitance of nondetubulated and detubulated myocytes and the peak LTCC current amplitudes recorded at Ϫ1 mV in these cells, we could assess the LTCC current density in these membrane compartments using Eqs. 7 and 8 (Fig. 4E ). There were no significant differences in whole cell LTCC current density between control and Iso-treated myocytes. In control myocytes, there was an ϳ4.5 times higher LTCC current density in the TT membrane than in the SS membrane. However, in Iso-treated myocytes, there was significantly higher SS and lower TT LTCC current density than in control myocytes. We found basically the same abnormal SS and TT LTCC current density in Iso-treated versus control myocytes in the presence of 1 mol/l propranolol in the external solution or with 10 mM BAPTA instead of 10 mM EGTA in the pipette solution (data not shown).
Mechanism underlying the altered SS and TT L-type Ca 2ϩ
current density in failing ventricular myocytes. Because the expression level of LTCC subunits was not changed in Isotreated versus control mice ( Fig. 2A) , the altered SS and TT LTCC current density in Iso-treated myocytes may be due to a change in the posttranslational modification of LTCCs. LTTC activity is enhanced by phosphorylation and suppressed by dephosphorylation (15, 24) . Chronic ␤-adrenergic receptor (␤-AR) stimulation downregulates the signaling pathways mediated by PKA and CaMKII and increases PP1 and PP2A activities (3, 30) . Thus, we analyzed how such alterations in kinase and PP activities affected LTCC currents in Iso-treated mice. Figure 5 and Supplemental Table 5 show the effects of drugs modifying kinases and PPs on SS and TT LTCC current densities. As shown in Fig. 5A , left, a nonselective kinase inhibitor, SP (100 nM), but not a PKA inhibitor, H-89 (1 mol/l), or a CaMKII inhibitor, KN-93 (1 mol/l), significantly decreased SS LTCC current density in control myocytes. An inhibitor of PP1 and PP2A, OA (10 mol/l), but not a PP2B inhibitor, CsA (10 mol/l), significantly increased current density. Thus, SS LTCCs in control myocytes were activated by kinases other than PKA or CaMKII and suppressed by PP1/2A. Iso activated PKA and CaMKII in cardiac myocytes (5, 35) . Iso (10 mol/l) significantly increased SS LTCC current density in control myocytes, and OA augmented the response, consistent with the suppression of SS LTCCs by PP1/2A. As shown in Fig. 5A , right, SP but not H-89, KN-93, OA, or CsA significantly affected SS LTCC current density in Iso-treated myocytes, indicating that LTCCs were again modulated by unidentified kinases but not PPs. Consistent with this notion, OA did not augment an Iso-induced increase in SS LTCC current density in Iso-treated myocytes. Thus, it is likely that SS LTCCs were activated by kinases in both control and Iso-treated myocytes but were more weakly suppressed by PP1/2A in Iso-treated myocytes than in control myocytes.
In the presence of SP (i.e., without the effect of activating kinases), SS LTCC current density was significantly higher in Iso-treated myocytes than in control myocytes (Fig. 5A) , indicating that the expression level of LTCCs in SS membranes could be higher in Iso-treated myocytes than in control myocytes. Nevertheless, the effect on LTCCs of Iso in the presence of OA (i.e., without the effect of PP1/2A) was significantly smaller in Iso-treated myocytes than in control myocytes, indicating that ␤-ARs were downregulated in Iso-treated myocytes. Figure 5B shows the results of the same experiments on TT LTCC current density. In control myocytes (Fig. 5B, left) , SP but not H-89, KN-93, OA, or CsA significantly affected TT LTCC current density in control myocytes. Iso significantly increased current density, but OA did not further increase the density. Thus, TT LTCCs were modulated by unidentified kinases but not PPs in control myocytes. On the other hand, as shown in Fig. 5B , right, OA doubled TT LTCC current density, whereas SP, H-89, KN-93, and CsA did not significantly affect current density in Iso-treated myocytes. Iso did not significantly increase TT LTCC current density, and OA nearly doubled the density in the presence of Iso. Thus, it is likely that TT LTCCs were less strongly activated by kinases and more strongly suppressed by PP1/2A in Iso-treated myocytes than in control myocytes.
DISCUSSION
In heart failure, ventricular myocytes experience different insults such as hemodynamic overload, chronic ␤-AR stimulation, activation of the renin-angiotensin-aldosterone system, etc. (21) . These factors cause functional and structural remodeling of the myocardium. We have confirmed that chronic ␤-AR stimulation on its own deteriorates the excitation-contraction coupling of ventricular myocytes (28, 30) . Iso-treated mice possess apparently intact t-tubules (Fig. 3) but exhibited overt heart failure ( Fig. 1 and Supplemental Tables 1-3 ). Iso probably caused this effect mainly through ␤ 1 -ARs because transgenic 5-to 15-fold overexpression of ␤ 1 -AR but not up to 200-fold overexpression of ␤ 2 -AR causes dilated cardiomyopathy (30) . A major finding in this study is that TT LTCC current density was halved, whereas SS LTCC current density was significantly increased, in ventricular myocytes of Isotreated versus control mice (Fig. 4E) . This abnormality was confirmed in the presence of propranolol (data not shown). Thus, it is likely that the abnormality resulted from the chronic but not acute effect of ␤-AR stimulation on ventricular myocytes. It is also unlikely that the change in intracellular Ca 2ϩ homeostasis secondarily altered SS and TT LTCC current density because we found basically the same results with 10 mM BAPTA instead of 10 mM EGTA in the pipette solution (data not shown). The expression levels of LTCC subunits were not altered in Iso-treated versus control myocytes (Fig.  2A) . The altered TT and SS LTCC densities in Iso-treated myocytes appeared to result mainly from a change in the regulation of LTCCs by kinases and PPs (Fig. 5) .
Alteration of LTCC currents in Iso-treated myocytes. In most hypertrophy and failure, whole cell LTCC current density Gmax, maximum conduction density; Erev, apparent reversal potential; E0.5_Act, half-maximum activation potential; kAct, slope factor of activation; Act, time constant for activation at Ϫ1 mV; E0.5_Inact, half-maximum inactivation potential; kInact, slope factor of inactivation; f0, fraction of a noninactivating component; Af_Inact, relative amplitude of the fast component of inactivation at Ϫ1 mV; f_Inact, time constant for the fast component of inactivation at Ϫ1 mV; As_Inact, relative amplitude of the slow component of inactivation at Ϫ1 mV; s_Inact, time constant for the slow component of inactivation at Ϫ1 mV; A0, relative amplitude of a noninactivating component at Ϫ1 mV; Af_Recov, relative amplitude of the fast component of recovery at Ϫ91 mV; f_Recov, time constant for the fast component of recovery at Ϫ91 mV; As_Recov, relative amplitude of the slow component of recovery at Ϫ91 mV; s_Recov, time constant for the slow component of recovery at Ϫ91 mV.
does not change markedly (2, 26) . However, Schröder et al. (31) found that in human failing ventricular myocytes, LTCC activity in the SS membrane was increased by ϳ200% in the cell-attached configuration of the patch-clamp technique. The authors ascribed this to the insufficient dephosphorylation of LTCCs by PP1/2A, consistent with our notion. Schröder et al. (31) also found that whole cell LTCC current density was nevertheless significantly different between the control and failed myocytes, indicating that TT LTCC current density might have been decreased in failed myocytes, as was the case in the present study (Fig. 4E) . In some forms of cardiac hypertrophy and failure, the amount of SR Ca 2ϩ release associated with LTCC openings decreases despite normal whole cell LTCC current density, RyR number, and SR Ca 2ϩ content (10, 11, 23) . This decrease in CICR gain was suggested to arise from a change in the microarchitecture of dyads (10, 11) or a disturbance of TT architecture (14) . However, we speculate that the reduced CICR gain might at least partially result from a decrease in TT LTCC current density. LTCC activity is regulated by phosphorylation and dephosphorylation (15, 24) . Chronic ␤-AR stimulation downregulates the signaling pathways mediated by PKA and CaMKII and increases PP1 and PP2A activities (3, 30) . Thus, we analyzed how such alterations in kinase and PP activities affected LTCC currents in Iso-treated mice. H-89, KN-93, and CsA did not significantly affect SS and TT LTCC current density (Fig. 5) . However, SP significantly reduced TT LTCC current density in control myocytes but not Iso-treated myocytes, whereas OA significantly increased TT LTCC current density in Iso-treated myocytes but not in control myocytes (Fig. 5B) . Notably, TT LTCC current density in the presence of SP was comparable in control and Iso-treated myocytes and not significantly different from that in the presence of DMSO in Iso-treated myocytes; TT LTCC current density in the presence of OA was comparable in control and Iso-treated myocytes and similar to that in the presence of DMSO in control myocytes. Thus, the lower TT LTCC current density in Iso-treated myocytes than in control myocytes seemed to result from insufficient activation by kinases other than PKA or CaMKII and excessive suppression by PP1/2A. SS LTCCs were activated by unidentified kinases in both control and Iso-treated myocytes, whereas this reaction was more weakly counteracted by PP1/2A in Isotreated myocytes than in control myocytes (Fig. 5A) . Thus, the higher SS LTCC current density in Iso-treated myocytes than in control myocytes seemed to result from the insufficient suppression of SS LTCCs by PP1/2A. Further studies are necessary to identify the kinases involved in these reactions and their functional significance in heart failure. On the other hand, total PP1/2A activity has been shown to increase in failing ventricular myocytes of rats chronically treated with Iso (3). The present study suggests that the activity of these PPs was enhanced for TT LTCCs but reduced for SS LTCCs in Iso-treated myocytes. Such a differential effect of PPs on these LTCCs may be enabled by the direct association of PPs to LTCC ␣ 1C -subunits (6, 12) .
It is uncertain why TT LTCC current density decreased in Iso-treated myocytes. However, the decreased TT LTCC current density might represent an adaptation to heart failure. Brette et al. (4) suggested that APs in TT membranes with a high LTCC current density may be ϳ5.5 times longer than those of the SS membrane. Thus, decreased TT LTCC current density might serve to prevent excessive AP prolongation and the resultant fatal ventricular tachyarrhythmias (37) , which are prone to occur in the failing myocardium with reduced outward K ϩ currents (Supplemental Fig. 1 ) (27) . This adaptation may be especially important during ␤-AR stimulation, which augments LTCC currents. In Iso-treated myocytes, the enhancement of PP1/2A activity strongly dampened the effect of ␤-AR stimulation on TT LTCCs (Fig. 5B) .
If the decreased TT LTCC current density is adaptation, it would significantly impair the cardiac function of Iso-treated mice. Further studies are necessary to assess the impact of this alteration on the intracellular Ca 2ϩ handling and contractility of Iso-treated myocytes.
Limitations. Caution should be exercised to extrapolate the present observations to heart failure in general. For instance, Iso-treated mice did not exhibit significantly higher mortality than control mice (data not shown). The TT structure was preserved in Iso-treated myocytes, although it is often disturbed in heart failure (14) . The expression of Ca 2ϩ -handling proteins such as PLB, SERCA2, and NCX1 was not significantly changed in Iso-treated versus control mice, whereas it is usually, if not always, altered in heart failure (2, 18, 29) . Thus, Iso-treated mice may suffer from modest heart failure compared with other animal models of heart failure or patients with end-stage heart failure. It is also noteworthy that excessive ␤-AR stimulation is one of the causes of deteriorating cardiac function in heart failure in general but the primary cause of cardiac dysfunctions in Iso-treated mice. Therefore, further studies are clearly needed to determine how many changes in Iso-treated myocytes are related to heart failure per se rather than adaptation to excessive ␤-AR stimulation. Nevertheless, we speculate that the decrease in TT LTCC current density would be found in heart failure in which the heart experiences excessive ␤-AR stimulation.
